Indications
Treatment of anaemia associated with chronic kidney disease (CKD) in adults.
Composition
- Active substance
- daprodustat
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Jesduvroq
- Active substance
- daprodustat
- ATC code
- B03XA
- Therapeutic area
- Renal Insufficiency, Chronic, Anemia
- Marketing authorisation holder
- GlaxoSmithKline Trading Services Limited
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/005746